Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model

Detalhes bibliográficos
Autor(a) principal: Boissonnet, Carlos P.
Data de Publicação: 2020
Outros Autores: Giorgi, Mariano A., Carosella, Lucila, Brescacín, Carola, Pissinis, Jerónimo, Guetta, Javier N.
Tipo de documento: preprint
Idioma: spa
Título da fonte: SciELO Preprints
Texto Completo: https://preprints.scielo.org/index.php/scielo/preprint/view/681
Resumo: COVID-19 pandemic is challenging Latin American health systems, which could benefit from information to make appropriate decisions in contexts of constrained health resources.Objective: to evaluate, in adult patients with suspected mild clinical forms of COVID-19, the clinical effectiveness (life expectancy) and resource consumption (days of hospitalization) of different management strategies.Methods: stochastic decision tree comparing the conventional strategy recommended by WHO - PAHO (diagnostic test for COVID-19 and hospitalization of patients testing positive) versus two alternative strategies (immediate addition of a prognostic test with hospitalization according to its result, or follow-up with hospitalization only in case of clinical deterioration).Results: the alternative management strategies showed expected clinical utility similar to the conventional strategy in 80 years-old base cases, and slightly lower in 60 years- and 40 years-old base cases, with lower consumption of hospitalization days. In sensitivity analysis, alternative strategies comparatively improved their expected clinical utility given a lower sensitivity of the diagnostic test or a higher ability of the follow-up to detect clinical worsening.Conclusions: in cases of suspected COVID-19 without pneumonic infiltrate or signs of severity, alternative strategies can be considered to avoid hospitalization for the majority of patients, especially if efficient follow-up modalities can be implemented. This information is valuable for health decision-makers, to carefully weight clinical and epidemiological elements and design locally feasible strategies.
id SCI-1_2a2a9671189c006dd7f02374874b60a0
oai_identifier_str oai:ops.preprints.scielo.org:preprint/681
network_acronym_str SCI-1
network_name_str SciELO Preprints
repository_id_str
spelling Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision ModelEstrategias de manejo clínico de casos leves de COVID-19 en América Latina: Modelo de decisiónInfecciones por coronavirusModelos teóricosAsignación de recursosCoronavirus infectionsTheoretical modelsResource allocationCOVID-19 pandemic is challenging Latin American health systems, which could benefit from information to make appropriate decisions in contexts of constrained health resources.Objective: to evaluate, in adult patients with suspected mild clinical forms of COVID-19, the clinical effectiveness (life expectancy) and resource consumption (days of hospitalization) of different management strategies.Methods: stochastic decision tree comparing the conventional strategy recommended by WHO - PAHO (diagnostic test for COVID-19 and hospitalization of patients testing positive) versus two alternative strategies (immediate addition of a prognostic test with hospitalization according to its result, or follow-up with hospitalization only in case of clinical deterioration).Results: the alternative management strategies showed expected clinical utility similar to the conventional strategy in 80 years-old base cases, and slightly lower in 60 years- and 40 years-old base cases, with lower consumption of hospitalization days. In sensitivity analysis, alternative strategies comparatively improved their expected clinical utility given a lower sensitivity of the diagnostic test or a higher ability of the follow-up to detect clinical worsening.Conclusions: in cases of suspected COVID-19 without pneumonic infiltrate or signs of severity, alternative strategies can be considered to avoid hospitalization for the majority of patients, especially if efficient follow-up modalities can be implemented. This information is valuable for health decision-makers, to carefully weight clinical and epidemiological elements and design locally feasible strategies.La pandemia COVID-19 desafía los sistemas de salud de Latinoamérica, que podrían beneficiarse de información para tomar decisiones apropiadas, en contextos de escasez de recursos sanitarios.Objetivo: evaluar, en pacientes adultos con sospecha de formas clínicas leves de COVID-19, la efectividad clínica (expectativa de vida) y el consumo de recursos (días de hospitalización) de distintas estrategias de manejo. Métodos: árbol de decisión estocástico, comparando la estrategia convencional recomendada por OMS - OPS (prueba diagnóstica para COVID-19 y hospitalización ante resultado positivo) versus dos estrategias alternativas (agregado inmediato de una prueba pronóstica con hospitalización según ese resultado, y seguimiento con hospitalización sólo ante empeoramiento clínico). Resultados: las estrategias de manejo alternativas mostraron utilidad clínica esperada similar a la estrategia convencional en casos base de 80 años de edad, y ligeramente inferior en casos base de 60 años y 40 años de edad, con menor consumo de días de hospitalización. En el análisis de sensibilidad, las estrategias alternativas mejoraron comparativamente su utilidad clínica esperada si la sensibilidad de la prueba diagnóstica fuera menor o la capacidad del seguimiento para detectar empeoramiento clínico fuera mayor. Conclusiones: ante casos sospechosos de COVID-19 sin infiltrado neumónico ni signos de gravedad, pueden considerarse estrategias que eviten la hospitalización de la mayoría de los pacientes, en especial si pueden implementarse modalidades de seguimiento eficientes. Esta información es valiosa para los decisores en salud, para analizar ponderadamente elementos clínicos y epidemiológicos y diseñar estrategias factibles localmente.SciELO PreprintsSciELO PreprintsSciELO Preprints2020-06-02info:eu-repo/semantics/preprintinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://preprints.scielo.org/index.php/scielo/preprint/view/68110.1590/SciELOPreprints.681spahttps://preprints.scielo.org/index.php/scielo/article/view/681/899Copyright (c) 2020 Carlos Boissonnet, Mariano Giorgi, Lucila Carosella, Carola Brescacín, Jerónimo Pissinis, Javier Guettahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessBoissonnet, Carlos P.Giorgi, Mariano A.Carosella, LucilaBrescacín, CarolaPissinis, JerónimoGuetta, Javier N.reponame:SciELO Preprintsinstname:SciELOinstacron:SCI2020-05-31T20:11:11Zoai:ops.preprints.scielo.org:preprint/681Servidor de preprintshttps://preprints.scielo.org/index.php/scieloONGhttps://preprints.scielo.org/index.php/scielo/oaiscielo.submission@scielo.orgopendoar:2020-05-31T20:11:11SciELO Preprints - SciELOfalse
dc.title.none.fl_str_mv Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model
Estrategias de manejo clínico de casos leves de COVID-19 en América Latina: Modelo de decisión
title Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model
spellingShingle Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model
Boissonnet, Carlos P.
Infecciones por coronavirus
Modelos teóricos
Asignación de recursos
Coronavirus infections
Theoretical models
Resource allocation
title_short Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model
title_full Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model
title_fullStr Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model
title_full_unstemmed Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model
title_sort Clinical Management Strategies in Mild COVID-19 cases in Latin-America: A Decision Model
author Boissonnet, Carlos P.
author_facet Boissonnet, Carlos P.
Giorgi, Mariano A.
Carosella, Lucila
Brescacín, Carola
Pissinis, Jerónimo
Guetta, Javier N.
author_role author
author2 Giorgi, Mariano A.
Carosella, Lucila
Brescacín, Carola
Pissinis, Jerónimo
Guetta, Javier N.
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Boissonnet, Carlos P.
Giorgi, Mariano A.
Carosella, Lucila
Brescacín, Carola
Pissinis, Jerónimo
Guetta, Javier N.
dc.subject.por.fl_str_mv Infecciones por coronavirus
Modelos teóricos
Asignación de recursos
Coronavirus infections
Theoretical models
Resource allocation
topic Infecciones por coronavirus
Modelos teóricos
Asignación de recursos
Coronavirus infections
Theoretical models
Resource allocation
description COVID-19 pandemic is challenging Latin American health systems, which could benefit from information to make appropriate decisions in contexts of constrained health resources.Objective: to evaluate, in adult patients with suspected mild clinical forms of COVID-19, the clinical effectiveness (life expectancy) and resource consumption (days of hospitalization) of different management strategies.Methods: stochastic decision tree comparing the conventional strategy recommended by WHO - PAHO (diagnostic test for COVID-19 and hospitalization of patients testing positive) versus two alternative strategies (immediate addition of a prognostic test with hospitalization according to its result, or follow-up with hospitalization only in case of clinical deterioration).Results: the alternative management strategies showed expected clinical utility similar to the conventional strategy in 80 years-old base cases, and slightly lower in 60 years- and 40 years-old base cases, with lower consumption of hospitalization days. In sensitivity analysis, alternative strategies comparatively improved their expected clinical utility given a lower sensitivity of the diagnostic test or a higher ability of the follow-up to detect clinical worsening.Conclusions: in cases of suspected COVID-19 without pneumonic infiltrate or signs of severity, alternative strategies can be considered to avoid hospitalization for the majority of patients, especially if efficient follow-up modalities can be implemented. This information is valuable for health decision-makers, to carefully weight clinical and epidemiological elements and design locally feasible strategies.
publishDate 2020
dc.date.none.fl_str_mv 2020-06-02
dc.type.driver.fl_str_mv info:eu-repo/semantics/preprint
info:eu-repo/semantics/publishedVersion
format preprint
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://preprints.scielo.org/index.php/scielo/preprint/view/681
10.1590/SciELOPreprints.681
url https://preprints.scielo.org/index.php/scielo/preprint/view/681
identifier_str_mv 10.1590/SciELOPreprints.681
dc.language.iso.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://preprints.scielo.org/index.php/scielo/article/view/681/899
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv SciELO Preprints
SciELO Preprints
SciELO Preprints
publisher.none.fl_str_mv SciELO Preprints
SciELO Preprints
SciELO Preprints
dc.source.none.fl_str_mv reponame:SciELO Preprints
instname:SciELO
instacron:SCI
instname_str SciELO
instacron_str SCI
institution SCI
reponame_str SciELO Preprints
collection SciELO Preprints
repository.name.fl_str_mv SciELO Preprints - SciELO
repository.mail.fl_str_mv scielo.submission@scielo.org
_version_ 1797047818489167872